FDA Approved: CABENUVA — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for CABENUVA, the monthly injectable regimen of cabotegravir and rilpivirine, submitted by ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CABENUVA (cabotegravir and rilpivirine)

Snippet

SUPPL AP for CABENUVA (CABOTEGRAVIR AND RILPIVIRINE)